Cargando…

High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy

PURPOSE: To investigate the association between the 2 acute phase proteins, C-reactive protein (CRP) and pentraxin 3 (PTX3) with central serous chorioretinopathy (CSCR), as PTX3 is a glucocorticoid-induced protein. DESIGN: Cross-sectional multicenter study. PARTICIPANTS: Patients with CSCR compared...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bousquet, Elodie, Chenevier-Gobeaux, Camille, Jaworski, Thara, Torres-Villaros, Héloïse, Zola, Marta, Mantel, Irmela, Kowalczuk, Laura, Matet, Alexandre, Daruich, Alejandra, Zhao, Min, Yzer, Suzanne, Behar-Cohen, Francine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025279/ https://www.ncbi.nlm.nih.gov/pubmed/36950301 http://dx.doi.org/10.1016/j.xops.2023.100278

Ejemplares similares

Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy
por: Matet, A., et al.
Publicado: (2020)

Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men
por: Bousquet, Elodie, et al.
Publicado: (2022)

ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration
por: Daruich, Alejandra, et al.
Publicado: (2017)

Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
por: Zola, Marta, et al.
Publicado: (2023)

Levels of the oxidative stress biomarker malondialdehyde in tears of patients with central serous chorioretinopathy relate to disease activity
por: Daruich, Alejandra, et al.
Publicado: (2020)

Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study
por: Kowalczuk, Laura, et al.
Publicado: (2018)

Mid-Phase Hyperfluorescent Plaques Seen on Indocyanine Green Angiography in Patients with Central Serous Chorioretinopathy
por: Bousquet, Elodie, et al.
Publicado: (2021)

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy
por: Daruich, Alejandra, et al.
Publicado: (2016)

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE
por: Kowalczuk, Laura, et al.
Publicado: (2017)

CENTRAL SEROUS CHORIORETINOPATHY: High-Resolution Imaging of Asymptomatic Fellow Eyes Using Adaptive Optics Scanning Laser Ophthalmoscopy
por: Gerardy, Melvin, et al.
Publicado: (2022)

Resolution of foveal detachment in dome-shaped macula after treatment by spironolactone: report of two cases and mini-review of the literature
por: Dirani, Ali, et al.
Publicado: (2014)

SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study
por: Bousquet, Elodie, et al.
Publicado: (2015)

Management of central serous chorioretinopathy: Expert panel discussion
por: Chhablani, Jay, et al.
Publicado: (2018)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2020)

Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration
por: Mantel, Irmela, et al.
Publicado: (2019)

Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model
por: Daruich, Alejandra, et al.
Publicado: (2021)

Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2019)

CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

OCT Angiography Fractal Analysis of Choroidal Neovessels Secondary to Central Serous Chorioretinopathy, in a Caucasian Cohort
por: Serra, Rita, et al.
Publicado: (2022)

Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy
por: Zakir, Shaik M, et al.
Publicado: (2009)

Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy
por: Karska‐Basta, Izabella, et al.
Publicado: (2020)

Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
por: Chrząszcz, Michał, et al.
Publicado: (2021)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Cadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy
por: Schubert, Carl, et al.
Publicado: (2014)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati, Danial, et al.
Publicado: (2018)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2018)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Central serous chorioretinopathy in pregnancy
por: Ochinciuc, Radu, et al.
Publicado: (2022)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous Chorioretinopathy
por: Natung, Tanie, et al.
Publicado: (2015)

Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy
por: Karska-Basta, Izabella, et al.
Publicado: (2021)

Central serous chorioretinopathy secondary to trauma
por: Jackson, Thomas E., et al.
Publicado: (2012)

Central Serous Chorioretinopathy after Rhinoplasty
por: Moschos, Marilita M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8vcelv5gumhhu8rkthck7nhp1q